The Far-UVC 222nm light technology, a product of the strategic partnership with Acuity Brands, is acclaimed for its ability to inactivate harmful pathogens, including viruses and bacteria, while being safe for human exposure. The installation of Puro Protect 222nm fixtures at
This deployment highlights a tremendous opportunity in the sterile processing space, essential in most acute care facilities. The Sterile Processing Departments (SPDs) are vital for maintaining a sterile environment, and the introduction of PURO Protect technology, co-developed with Acuity Brands, is set to revolutionize standard hygiene and safety protocols across the healthcare industry. We estimate that the potential just in this one space is over
This initiative reflects the joint commitment of
For more information about PURO UV Disinfection Lighting and its innovative solutions, visit PUROLighting.com.
About Applied UV
More details about
Forward-Looking Statements
The information contained herein may contain “forward‐looking statements.” Forward‐looking statements reflect the current view about future events. When used in this press release, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” or the negative of these terms and similar expressions, as they relate to us or our management, identify forward‐looking statements. Such statements include, but are not limited to, statements contained in this press release relating to its business strategy. Forward‐looking statements are based on the Company’s current expectations and assumptions regarding its business, the economy and other future conditions. Because forward–looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company’s actual results may differ materially from those contemplated by the forward‐looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward‐looking statements. Factors or events that could cause the Company’s actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. These forward-looking statements and factors that may cause such differences include, without limitation, the risks disclosed in the Company’s Annual Report on Form 10-K filed with the
For Additional Company Information:
Applied UV Founder, CEO & Director
Max.munn@applieduvinc.com
Investor Relations Contact:
TraDigital IR
+1-646-418-7002
kevin@tradigitalir.com
Source:
2023 GlobeNewswire, Inc., source